Correlation Between Mereo BioPharma and Burning Rock

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Mereo BioPharma and Burning Rock at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mereo BioPharma and Burning Rock into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mereo BioPharma Group and Burning Rock Biotech, you can compare the effects of market volatilities on Mereo BioPharma and Burning Rock and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mereo BioPharma with a short position of Burning Rock. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mereo BioPharma and Burning Rock.

Diversification Opportunities for Mereo BioPharma and Burning Rock

-0.74
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Mereo and Burning is -0.74. Overlapping area represents the amount of risk that can be diversified away by holding Mereo BioPharma Group and Burning Rock Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Burning Rock Biotech and Mereo BioPharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mereo BioPharma Group are associated (or correlated) with Burning Rock. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Burning Rock Biotech has no effect on the direction of Mereo BioPharma i.e., Mereo BioPharma and Burning Rock go up and down completely randomly.

Pair Corralation between Mereo BioPharma and Burning Rock

Given the investment horizon of 90 days Mereo BioPharma Group is expected to under-perform the Burning Rock. But the stock apears to be less risky and, when comparing its historical volatility, Mereo BioPharma Group is 1.0 times less risky than Burning Rock. The stock trades about -0.34 of its potential returns per unit of risk. The Burning Rock Biotech is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest  650.00  in Burning Rock Biotech on October 25, 2024 and sell it today you would earn a total of  31.00  from holding Burning Rock Biotech or generate 4.77% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy94.74%
ValuesDaily Returns

Mereo BioPharma Group  vs.  Burning Rock Biotech

 Performance 
       Timeline  
Mereo BioPharma Group 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Mereo BioPharma Group has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in February 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
Burning Rock Biotech 

Risk-Adjusted Performance

18 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Burning Rock Biotech are ranked lower than 18 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, Burning Rock reported solid returns over the last few months and may actually be approaching a breakup point.

Mereo BioPharma and Burning Rock Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Mereo BioPharma and Burning Rock

The main advantage of trading using opposite Mereo BioPharma and Burning Rock positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mereo BioPharma position performs unexpectedly, Burning Rock can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Burning Rock will offset losses from the drop in Burning Rock's long position.
The idea behind Mereo BioPharma Group and Burning Rock Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.

Other Complementary Tools

Content Syndication
Quickly integrate customizable finance content to your own investment portal
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Commodity Directory
Find actively traded commodities issued by global exchanges
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios